{"url_path":"/sec/imnn/8-k/2026-06-30/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-30","source_url":"https://www.sec.gov/Archives/edgar/data/749647/0001493152-26-031292-index.html","accession_number":"0001493152-26-031292","cik":"0000749647","ticker":"IMNN","issuer_name":"Imunon, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/749647/0001493152-26-031292-index.html","primary_entity_key":"0000749647","primary_entity_name":"Imunon, Inc."},"word_count":88,"has_tables":true,"body_markdown":"**Item\n9.01 Financial Statements and Exhibits.**\n\n \n\n(d)\nExhibits.\n\n \n\n**Exhibit**\n\n**No.**\n\n \n**Description**\n\n \n \n \n\n10.1\n \n[Master Services Agreement, dated June 24, 2026, by and between Imunon, Inc. and Danforth Health, Inc.](ex10-1.htm)\n\n104\n \nCover\nPage Interactive Data File (embedded within the Inline XBRL document)\n\n \n\n \n\n \n\n \n\n**SIGNATURES**\n\n \n\nPursuant\nto the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by\nthe undersigned hereunto duly authorized.\n\n \n\n \n**IMUNON\nINC.**\n\n \n \n \n\nDated:\nJune 30, 2026\nBy:\n*/s/\nSusan Eylward*\n\n \n \nSusan\nEylward\n\n \n \nGeneral\nCounsel and Corporate Secretary"}